Literature DB >> 11958946

Low doses of naltrexone reduce palatability and consumption of ethanol in outbred rats.

Daniel L Coonfield1, Katherine G Hill, Helen J Kaczmarek, Frank M Ferraro, Stephen W Kiefer.   

Abstract

The opioid antagonist naltrexone, at doses of 1 and 3 mg/kg, has been shown to decrease the palatability and consumption of 10% ethanol in rats. However, a dose of 0.5 mg/kg of naltrexone has produced equivocal results. The purpose of the present study was to clarify the effects of low doses of naltrexone (0.0 [control], 0.25, 0.50, 0.75, and 1.0 mg/kg) on palatability and consumption of 10% ethanol. Sixty-four, male, Long-Evans hooded rats were divided into five groups matched for ethanol consumption. Each rat was injected over four consecutive days with one of five doses of naltrexone exactly 30 min before taste reactivity testing with 10% ethanol. When reactivity testing was completed, rats were acclimated to drink during a period of restricted access to fluid under conditions of mild fluid deprivation. Then, on four consecutive test days, rats were injected with naltrexone 10 min before 10% ethanol was made available for 30 min. Although each dose of naltrexone decreased ingestive responding to 10% ethanol over four days, this effect was not statistically reliable. However, all doses of naltrexone produced significant increases in aversive responding to the ethanol solution. Naltrexone, at the three highest doses, produced significant decreases in consumption of 10% ethanol. These results were consistent with the interpretation that naltrexone, even at low doses, reliably reduces palatability and consumption of 10% ethanol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958946     DOI: 10.1016/s0741-8329(01)00180-x

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  20 in total

1.  Reduced alcohol consumption in mice lacking preprodynorphin.

Authors:  Yuri A Blednov; Danielle Walker; Marni Martinez; R Adron Harris
Journal:  Alcohol       Date:  2006-10       Impact factor: 2.405

2.  Mu-opioid receptor activation in the medial shell of nucleus accumbens promotes alcohol consumption, self-administration and cue-induced reinstatement.

Authors:  Jocelyn M Richard; Howard L Fields
Journal:  Neuropharmacology       Date:  2016-04-14       Impact factor: 5.250

Review 3.  The opioidergic-alcohol link : implications for treatment.

Authors:  Vania Modesto-Lowe; Eleanor M Fritz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  MC4-R signaling within the nucleus accumbens shell, but not the lateral hypothalamus, modulates ethanol palatability in rats.

Authors:  Jose M Lerma-Cabrera; Francisca Carvajal; Gabriela Chotro; Mirari Gaztañaga; Montserrat Navarro; Todd E Thiele; Inmaculada Cubero
Journal:  Behav Brain Res       Date:  2012-11-09       Impact factor: 3.332

5.  Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.

Authors:  Brendan M Walker; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-05-02       Impact factor: 7.853

6.  Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice.

Authors:  Arthur Tomie; Idu Azogu; Lei Yu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-13       Impact factor: 5.067

Review 7.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

8.  The opioid peptides enkephalin and beta-endorphin in alcohol dependence.

Authors:  Ildiko Racz; Britta Schürmann; Anna Karpushova; Martin Reuter; Sven Cichon; Christian Montag; Robert Fürst; Christian Schütz; Petra E Franke; Jana Strohmaier; Thomas F Wienker; Lars Terenius; Urban Osby; Agneta Gunnar; Wolfgang Maier; Andras Bilkei-Gorzó; Markus Nöthen; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2008-06-27       Impact factor: 13.382

9.  Appetitive motivational experience during adolescence results in enhanced alcohol consumption during adulthood.

Authors:  Brendan M Walker; Cindy L Ehlers
Journal:  Behav Neurosci       Date:  2009-08       Impact factor: 1.912

10.  Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.

Authors:  Vladana Vukojević; Yu Ming; Claudio D'Addario; Rudolf Rigler; Björn Johansson; Lars Terenius
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.